Stock Name | Novavax Inc |
Ticker | NVAX(USD) NASDAQ |
TYPE | Common Stock |
Country | USA |
ISIN | US6700024010 |
LEI | 529900J4GJHPEPQ23205 |
Ticker | NVAX(EUR) F |
Date | ETF ISIN/Name | Num Shares | Book value |
---|---|---|---|
2025-10-17 | IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) | 15,781 | USD 127,826 |
2025-10-17 | IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) | 187,141 | USD 1,515,842 |
2025-10-17 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | 102,147 | USD 827,391 |
2025-10-17 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | 102,147 | USD 827,391 |
2025-10-17 | IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) | 99,328 | USD 804,557 ![]() |
2025-10-17 | IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) | 1,523 | USD 12,336 ![]() |
Total = | 508,067 | USD 4,115,343 |